Cross-sectional Survey of Zhejiang ECMO Application

NCT04979325 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2021-07-28

No results posted yet for this study

Summary

Extracorporeal lung oxygenation (ECMO) was first used in neonates in the 1970s and is now widely used to treat adult patients with intractable shock and respiratory failure who have failed various types of conventional life support. According to the Extracorporeal Life Support Organization (ELSO), a total of 61,193 adult patients worldwide received ECMO in 2019. According to the Extracorporeal Life Support Organization (ELSO), a total of 61,193 adult patients were treated with ECMO worldwide in 2019, including 25,631 VV-ECOM, 12,836 VA, and 5086 ECPR. The number of ECMO cases and hospitals in Zhejiang province are increasing year by year, and they play an irreplaceable role in various critical care resuscitation, especially in response to public emergencies, but there is a lack of precise data on the current status of ECMO implementation. This study aims to investigate the implementation of ECMO, problems and needs of hospitals at all levels in Zhejiang Province, and provide reference for further improving the capacity and quality of ECMO application in the province.

Conditions

  • Extracorporeal Membrane Oxygenation
  • Cardiopulmonary Resuscitation
  • Epidemiology

Interventions

OTHER

Sponsors & Collaborators

  • Sir Run Run Shaw Hospital

    collaborator OTHER
  • Zhejiang Provincial People's Hospital

    collaborator OTHER
  • Zhejiang Hospital

    collaborator OTHER
  • The First Affiliated Hospital of Zhejiang Chinese Medical University

    collaborator OTHER
  • First People's Hospital of Hangzhou

    collaborator OTHER
  • The Affiliated Hospital of Hangzhou Normal University

    collaborator OTHER
  • The Third People's Hospital of Hangzhou

    collaborator OTHER
  • Red Cross Hospital, Hangzhou, China

    collaborator OTHER
  • Hangzhou Children's Hospital

    collaborator UNKNOWN
  • The First Hospital of Fuyang District, Hangzhou

    collaborator UNKNOWN
  • The First Hospital of Xiaoshan District, Hangzhou

    collaborator UNKNOWN
  • The First Hospital of Linping District, Hangzhou

    collaborator UNKNOWN
  • The First Hospital of Lin'an District, Hangzhou

    collaborator UNKNOWN
  • The First Hospital of Tonglu County, Hangzhou

    collaborator UNKNOWN
  • The First Hospital of Jiande County, Hangzhou

    collaborator UNKNOWN
  • The First Hospital of Chun'an County, Hangzhou

    collaborator UNKNOWN
  • Affiliated Cixi Hospital of Wenzhou Medical University

    collaborator OTHER
  • Ningbo Medical Center Lihuili Hospital

    collaborator OTHER_GOV
  • Ningbo First People's Hospital

    collaborator UNKNOWN
  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Principal Investigators

  • Bin Zhang, masters · Departmental staff

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2021-08-30
Completion
2021-09-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04979325 on ClinicalTrials.gov